4
Total investments
2
Early stage
1
Mid stage
0
Late stage
9y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Dec 2025
aKen Medical is a biotechnology company that encapsulates highly potent radioactive materials within stable nanoparticles serving as "guided missiles" that deliver targeted radiation straight to tumors while protecting healthy tissue. Our universal nanoparticle platform is designed to address a wide range of cancers, enabling real-time monitoring and advancing a theranostic approach that paves the way for precision medicine.
Board Member
Feb 2024
YesBoss is an AI-driven personal assistant, engineered with a human-centric approach. It understands your priorities to organize both your professional and personal life: meetings, bookings and more.
Advisor, investor
Jul 2017
Robeauté is pioneering a new class of therapeutic microrobots—engineered to diagnose, treat and monitor the brain with unprecedented flexibility and precision. We are a pluridisciplinary and multicultural team of passionate, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must.
Our team is growing and we are constantly on the lookout for incredible talent and grit.
We are based in Paris, France.
Check out our open roles: https://apply.workable.com/robeaute/
Follow us here as we tell you more of what we do.
Experience · 9 entries
All (9)
Investments (4)
Founder (1)
Board (1)
2025
Investor
Dec 2025
aKen Medical is a biotechnology company that encapsulates highly potent radioactive materials within stable nanoparticles serving as "guided missiles" that deliver targeted radiation straight to tumors while protecting healthy tissue. Our universal nanoparticle platform is designed to address a wide range of cancers, enabling real-time monitoring and advancing a theranostic approach that paves the way for precision medicine.
Business Angel - Investor
Oct 2025
Investessor est le premier réseau de Business Angels en France.
Les 300 Membres dInvestessor accompagnent et financent des projets à fort potentiel de tous secteurs dactivité principalement en Île-de-France. Investessor répond annuellement à plus de 1000 porteurs de projets, examine plus de 500 dossiers et sélectionne 50 entrepreneurs pour présentation devant ses Business Angels.
Depuis près de 17 ans, les Angels dInvestessor, maintenant accompagnés par le fonds dinvestissement Sibessor 2 et la plateforme de crowdfunding WeLikeStartup, ont financé plus de 200 projets innovants qui, par leur potentiel dactivité, ont apporté en 2013 près de 120 millions deuros de chiffre daffaires et 1.800 emplois à la Région Île-de-France.
http://www.investessor.fr
2024
Board Member
Feb 2024
YesBoss is an AI-driven personal assistant, engineered with a human-centric approach. It understands your priorities to organize both your professional and personal life: meetings, bookings and more.
2022
Partner Sales Director (Telco, Media, Tech, Pro Services, Scale up)
Apr 2022
Were the #1 AI CRM—where humans with agents drive customer success together with AI, data, and Customer 360 apps on one platform.
Privacy Statement: http://www.salesforce.com/company/privacy/
2017
Advisor, investor
Jul 2017
Robeauté is pioneering a new class of therapeutic microrobots—engineered to diagnose, treat and monitor the brain with unprecedented flexibility and precision. We are a pluridisciplinary and multicultural team of passionate, supportive and creative people, at the crossroads of microrobotics, engineering and medicine. We are team players, with both classical and atypical backgrounds, so unconventional thinking is welcome and good communication skills are a must.
Our team is growing and we are constantly on the lookout for incredible talent and grit.
We are based in Paris, France.
Check out our open roles: https://apply.workable.com/robeaute/
Follow us here as we tell you more of what we do.
Show all 9 entries ↓
Investment activity
2017–2025 · 4 investments
Recent (last 2 years)Earlier
